Diagnosing Rare Mendelian Disorders in the Genomic Era
- Webinar | 23. 09. 21

We are pleased to invite you to our on-demand webinar with Dr. Hane Lee, a former UCLA clinical professor and Chief Genomics Officer at 3billion, as a speaker.
The webinar will cover:
– How diagnosing rare Mendelian disorders in the genomic era has been evolving
– The diagnostic performance of exome sequencing
– The uniqueness of 3billion’s exome sequencing test
– 3billion’s involvement in South Korea’s national genome project and interesting case examples
The webinar is recommended for healthcare providers:
– interested in learning about genetic testing
– considering ordering genetic testing for patients with rare diseases
– debating which genetic test to order
– interested in learning about the latest improvements in genetic testing
If you are interested in NGS-based genomic testing, technical advancement in variant interpretation using AI (artificial intelligence) and 3billion’s services, join now!
3 billion bases to 1 answer : Diagnosing Rare Mendelian Disorders in the Genomic Era
- Speaker
- Hane Lee Ph.D.
- Role
- Chief Genomics Officer (CGO) at 3billion

Do you find this post helpful?
Click the button below to copy and share the link.

3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.